First Eagle Investment Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-29,667
| Closed | -$1.8M | – | 333 |
|
|
2016
Q3 | $1.8M | Hold |
29,667
| – | – | ﹤0.01% | 222 |
|
|
2016
Q2 | $1.95M | Sell |
29,667
-12,302
| -29% | -$810K | 0.01% | 225 |
|
|
2016
Q1 | $2.38M | Buy |
41,969
+3,333
| +9% | +$189K | 0.01% | 197 |
|
|
2015
Q4 | $9.09M | Buy |
38,636
+1,333
| +4% | +$314K | 0.02% | 163 |
|
|
2015
Q3 | $5.9M | Hold |
37,303
| – | – | 0.01% | 170 |
|
|
2015
Q2 | $14.1M | Hold |
37,303
| – | – | 0.03% | 155 |
|
|
2015
Q1 | $15.6M | Hold |
37,303
| – | – | 0.04% | 152 |
|
|
2014
Q4 | $10.2M | Buy |
37,303
+20,636
| +124% | +$5.65M | 0.02% | 163 |
|
|
2014
Q3 | $3.24M | Buy |
+16,667
| New | +$3.24M | 0.01% | 199 |
|
|
2014
Q1 | – | Sell |
-9,000
| Closed | -$3.27M | – | 387 |
|
|
2013
Q4 | $3.27M | Sell |
9,000
-27,667
| -75% | -$10M | 0.01% | 176 |
|
|
2013
Q3 | $19.5M | Sell |
36,667
-7,704
| -17% | -$4.09M | 0.06% | 137 |
|
|
2013
Q2 | $10.4M | Buy |
+44,371
| New | +$10.4M | 0.03% | 169 |
|